Clinical Trial Update: Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon [Phase 2]

View source ↗

Summary

Phase 2 dose-response clinical trial of a topical gel for Raynaud's phenomenon has completed. The study included participants with Raynaud's phenomenon secondar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon
• Raynaud Phenomenon Secondary to Autoimmune Disease
• Raynaud Phenomenon Secondary to Scleroderma

Snippet

Sponsor: MediQuest Therapeutics | Conditions: Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma | Phase 2 | Status: COMPLETED